Mark Clendenning
Title
Cited by
Cited by
Year
Feasibility of screening for Lynch syndrome among patients with colorectal cancer
H Hampel, WL Frankel, E Martin, M Arnold, K Khanduja, P Kuebler, ...
Journal of Clinical Oncology 26 (35), 5783, 2008
7942008
Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients
H Hampel, W Frankel, J Panescu, J Lockman, K Sotamaa, D Fix, ...
Cancer research 66 (15), 7810-7817, 2006
5672006
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
L Senter, M Clendenning, K Sotamaa, H Hampel, J Green, JD Potter, ...
Gastroenterology 135 (2), 419-428. e1, 2008
5112008
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database
BA Thompson, AB Spurdle, JP Plazzer, MS Greenblatt, K Akagi, ...
Nature genetics 46 (2), 107-115, 2014
3622014
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study
AK Win, JP Young, NM Lindor, KM Tucker, DJ Ahnen, GP Young, ...
Journal of clinical oncology 30 (9), 958, 2012
3032012
Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics
K Lagerstedt Robinson, T Liu, J Vandrovcova, B Halvarsson, ...
Journal of the national cancer institute 99 (4), 291-299, 2007
2592007
Cancer Risks for MLH1 and MSH2 Mutation Carriers
JG Dowty, AK Win, DD Buchanan, NM Lindor, FA Macrae, M Clendenning, ...
Human mutation 34 (3), 490-497, 2013
1982013
Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome
AK Win, NM Lindor, JP Young, FA Macrae, GP Young, E Williamson, ...
Journal of the National Cancer Institute 104 (18), 1363-1372, 2012
1972012
Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for …
DD Buchanan, YY Tan, MD Walsh, M Clendenning, AM Metcalf, ...
Journal of clinical oncology 32 (2), 90, 2014
1552014
Prevalence and penetrance of major genes and polygenes for colorectal cancer
AK Win, MA Jenkins, JG Dowty, AC Antoniou, A Lee, GG Giles, ...
Cancer Epidemiology and Prevention Biomarkers 26 (3), 404-412, 2017
1422017
Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype
MD Walsh, M Clendenning, E Williamson, SA Pearson, RJ Walters, ...
Modern Pathology 26 (12), 1642-1656, 2013
1412013
Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer
AK Win, JG Dowty, SP Cleary, H Kim, DD Buchanan, JP Young, ...
Gastroenterology 146 (5), 1208-1211. e5, 2014
1272014
Colorectal carcinomas with KRAS mutation are associated with distinctive morphological and molecular features
C Rosty, JP Young, MD Walsh, M Clendenning, RJ Walters, S Pearson, ...
Modern Pathology 26 (6), 825-834, 2013
1272013
PIK3CA activating mutation in colorectal carcinoma: associations with molecular features and survival
C Rosty, JP Young, MD Walsh, M Clendenning, K Sanderson, RJ Walters, ...
PloS one 8 (6), e65479, 2013
1242013
BRAFV600E immunohistochemistry facilitates universal screening of colorectal cancers for Lynch syndrome
CW Toon, MJ Walsh, A Chou, D Capper, A Clarkson, L Sioson, S Clarke, ...
The American journal of surgical pathology 37 (10), 1592, 2013
1142013
Long‐range PCR facilitates the identification of PMS2‐specific mutations
M Clendenning, H Hampel, J LaJeunesse, A Lindblom, J Lockman, ...
Human mutation 27 (5), 490-495, 2006
1002006
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps, S Tejpar, ...
Annals of Oncology 28 (5), 1023-1031, 2017
942017
Cancer risks for relatives of patients with serrated polyposis
AK Win, RJ Walters, DD Buchanan, MA Jenkins, K Sweet, WL Frankel, ...
The American journal of gastroenterology 107 (5), 770, 2012
942012
Lynch syndrome–associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry
MD Walsh, DD Buchanan, MC Cummings, SA Pearson, ST Arnold, ...
Clinical Cancer Research 16 (7), 2214-2224, 2010
852010
Aspirin, ibuprofen, and the risk for colorectal cancer in Lynch Syndrome
D Ait Ouakrim, SG Dashti, R Chau, DD Buchanan, M Clendenning, ...
JNCI: Journal of the National Cancer Institute 107 (9), 2015
812015
The system can't perform the operation now. Try again later.
Articles 1–20